These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23787421)

  • 1. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
    Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
    Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
    Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
    Yarbrough WG; Whigham A; Brown B; Roach M; Slebos R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S98-101. PubMed ID: 17848307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
    Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
    J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a semi-conductor sequencing-based panel for genotyping of HPV-positive and HPV-negative oropharyngeal cancer: a retrospective pilot study.
    Ham JC; Tops BBJ; Driessen CML; van Raaij AWM; Slootweg PJ; Melchers WJG; Ligtenberg MJL; van Herpen CML
    Clin Otolaryngol; 2017 Jun; 42(3):681-686. PubMed ID: 27882657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Chiosea SI; Grandis JR; Lui VW; Diergaarde B; Maxwell JH; Ferris RL; Kim SW; Luvison A; Miller M; Nikiforova MN
    BMC Cancer; 2013 Dec; 13():602. PubMed ID: 24341335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
    Theurer JA; Stecho W; Yoo J; Kwan K; Wehrli B; Harry V; Black M; Pinto N; Winquist E; Palma D; Richter S; Barrett JW; Danielle MacNeil S; Fung K; Howlett CJ; Nichols AC
    Pathol Oncol Res; 2016 Jan; 22(1):35-40. PubMed ID: 26271341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Cortelazzi B; Verderio P; Ciniselli CM; Pizzamiglio S; Bossi P; Gloghini A; Gualeni AV; Volpi CC; Locati L; Pierotti MA; Licitra L; Pilotti S; Perrone F
    J Oral Pathol Med; 2015 Oct; 44(9):734-45. PubMed ID: 25495427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
    Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
    Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines.
    Nichols AC; Yoo J; Palma DA; Fung K; Franklin JH; Koropatnick J; Mymryk JS; Batada NN; Barrett JW
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):732-9. PubMed ID: 22911296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
    Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
    Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
    Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression.
    De Petrini M; Rittà M; Schena M; Chiusa L; Campisi P; Giordano C; Landolfo V; Pecorari G; Landolfo S
    New Microbiol; 2006 Jan; 29(1):25-33. PubMed ID: 16608122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
    Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer.
    Rittà M; Landolfo V; Mazibrada J; De Andrea M; Dell'Oste V; Caneparo V; Peretti A; Giordano C; Pecorari G; Garzaro M; Landolfo S
    New Microbiol; 2013 Apr; 36(2):133-44. PubMed ID: 23686119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.